Abiopharma

🔍 Seglem Trygve (Director)

Company: KNOT Offshore Partners LP (KNOP)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 1,250,000 shares of Series A Preferred Units at $20.0 per share (Direct)
  Date: 2026-06-15 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,458,333.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Units (Direct)
  Date: 2026-06-15 | Code: H | nature_of_ownership: By Knutsen NYK Offshore Tankers AS | shares_owned_after: 9,661,255.00 | Footnotes: F1
• Holds 0 shares of Common Units (Direct)
  Date: 2026-06-15 | Code: H | nature_of_ownership: By KNOT Offshore Partners GP LLC | shares_owned_after: 90,368.00 | Footnotes: F1
• Holds 0 shares of Class B Units (Direct)
  Date: 2026-06-15 | Code: H | nature_of_ownership: By Knutsen NYK Offshore Tankers AS | shares_owned_after: 252,405.00 | Footnotes: F1

Footnotes:

• F1: Knutsen NYK Offshore Tankers AS ("KNOT") owns 100% of KNOT Offshore Partners GP LLC (the "General Partner"), the general partner of KNOT Offshore Partners LP (the "Issuer"). The General Partner owns 640,278 general partner units in the Issuer, representing the general partner interest in the Issuer. KNOT is a joint venture between NYK Holding (Europe) B.V. and TS Shipping Invest AS ("TSSI"), each of which owns a 50% interest and has the power to appoint half of the members of the board of directors of KNOT. TSSI is a wholly owned subsidiary of Seglem Holding AS, of which 70% is owned by Trygve Seglem with the remainder owned by members of his immediate family. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission or beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.